RHYTHM PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

RHYTHM PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $54.30 million for the year ending 2025.

  • RHYTHM PHARMACEUTICALS, INC. showed a decrease of -39.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from RHYTHM PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 12 years of available data (2014 to 2025), RHYTHM PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 35,624.3%.
  • Historical annual values: Fiscal year 2025: $54.30 million | Fiscal year 2024: $89.14 million | Fiscal year 2023: $60.08 million | Fiscal year 2022: $127.68 million | Fiscal year 2021: $59.25 million | Fiscal year 2020: $100.85 million | Fiscal year 2019: $62.29 million | Fiscal year 2018: $49.54 million | Fiscal year 2017: $34.24 million | Fiscal year 2016: $6.54 million | Fiscal year 2015: $34.87 million | Fiscal year 2014: $152.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: